Article info
PDFClinical and epidemiological research
Extended report
MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis
- Correspondence to Professor Paul P Tak, Department of Clinical Immunology and Rheumatology, Room F4-105, Academic Medical Center, University of Amsterdam, P.O. box 22700, Amsterdam 1100 DE, The Netherlands; p.p.tak{at}amc.uva.nl
Citation
MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis
Publication history
- Received May 10, 2013
- Revised September 9, 2013
- Accepted November 6, 2013
- First published December 2, 2013.
Online issue publication
March 07, 2018
Article Versions
- Previous version (7 March 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions